TGFB1 and hematocrit: GW788388 antagonized the expression of potential fibrotic markers by inhibiting the expression and recruitment of SMAD proteins necessary for the activation of TGF-β1/TGF-β1RI/II complex and downstream signaling cascades, thus improving cardiac function in both Npr1 KO and HT mutant mice.